创新药黄金时代开启!政策+技术+国际化三重驱动,恒瑞H股首日飙升37%领跑行业新周期

金融小博士
24 May

创新药板块步入快速放量期,行业盈利能力明显增强。恒瑞医药H股上市盘中最高上涨超37%今日(5月23日),恒瑞医药(01276.HK)H股上市,该股开盘前暗盘最高上涨超30%。受恒瑞医药H股大涨带动,A/H股创新药概念齐涨,A股中众生药业涨停,海辰药业、泰格医药、阳光诺和、华海药业等上涨逾7%,港股创新药指数上涨超2%,对应的港股创新药ETF上涨2.69%。创新药板块投资逻辑与核心标的分析一、行业...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10